Postmenopausal estrogen therapy modulates nocturnal nonlinear heart rate dynamics

Area of Science:

• Cardiovascular Physiology
• Sleep Medicine
• Endocrinology

Background:

• Postmenopausal estrogen therapy (ET) is widely used for symptom management.
• Heart rate variability (HRV) reflects autonomic nervous system function and cardiovascular health.
• Nocturnal HRV analysis provides insights into cardiac regulation during sleep.

Purpose of the Study:

• To investigate the impact of transdermal estradiol therapy on nocturnal nonlinear heart rate variability (HRV) in healthy postmenopausal women.
• To assess changes in HRV complexity during different sleep stages under ET.

Main Methods:

• A prospective, randomized, double-blind, placebo-controlled crossover study involving 71 hysterectomized postmenopausal women.
• Participants received transdermal estradiol or placebo for 3 months, followed by a 1-month washout and reversed treatment.
• Nocturnal nonlinear HRV parameters (fractal scaling exponents, approximate entropy, Poincaré plot variability) were analyzed during awake, light non-REM, deep non-REM (slow-wave), and REM sleep stages.

Main Results:

• Estrogen therapy (ET) significantly decreased nocturnal approximate entropy (ApEn), indicating reduced heart rate complexity, especially during slow-wave sleep.
• A significant decrease in SD2 was observed during slow-wave and REM sleep with ET.
• A slight increase in the fractal scaling exponent alpha1 was noted during light non-REM sleep with ET.

Conclusions:

• Estrogen therapy exerts a subtle but distinct attenuating effect on nocturnal nonlinear HRV measures, particularly on the complexity of heart rate dynamics.
• These findings suggest that ET may have potentially deleterious effects on cardiovascular health during sleep.
• Further research is warranted to elucidate the long-term cardiovascular implications of these HRV changes.